With the April 2022 recommendation that all U.S. adults between the ages of 19 and 59 years be vaccinated against hepatitis B virus (HBV), the CDC’s Advisory Committee on Immunization Practices (ACIP) hopes to significantly increase the number of people who are protected against this disease.
HBV is considered vaccine-preventable, but hepatitis B (HepB) vaccination rates historically have been low. Previously, HepB vaccines were only recommended for people considered at high